# CDT Equity Inc. (CDT)

> Source: Nexqual · https://nexqual.com/CDT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, CDT Equity Inc. (CDT), nexqual.com/CDT" · informational, not investment advice.

**Price:** USD 0.21 (-12.92% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.24 · day 0.18–0.22 · 52w 0.18–28,125 · market cap $235K · NCM

## Key facts
- Total return with dividends: 1Y -100.0% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2022-03-28) |
|---|---|---|
| Total return | -100.0% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -100.0% | -99.2% |
| Volatility (annualized) | 196.6% | 180.0% |
| Max drawdown | -100.0% (Oct 2025→Oct 2026) | -100.0% (Sep 2023→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CDT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt